Menu

Cardiol Therapeutics Inc. CRDL

Full chart Compare
Set alert

Price alert · CRDL

All alert types
1.00 USD +0.07 (+7.39%)

At closeNov 6, 2026, 5:03 PM EST

1.00 +0.01 +0.50%

After hours · Nov 6, 5:03 PM ET

0.94 Day range 1.00
0.926 52-week range 2.29
YTD
+4.30%
1 year
-2.45%

Revenue & Expenses

Other Income → Expenses: $5.56MExpenses → Gross Loss: $112.00KExpenses → Selling, General & Admin: $21.86MExpenses → Research & Development: $8.59MNet Loss → Expenses: $25.01MRevenue → Cost of Revenue: $62.27KOther Income$5.56MNet Loss$25.01MCost of Revenue$174.26KExpenses$30.57MGross Loss$112.00KSelling, General & Admin$21.86MResearch & Development$8.59MRevenue$62.27K

Latest period ending Dec 31, 2025 · select a line to chart its full history

CRDL annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-34.32M-40.28M-29.79M-41.34M-38.66M
-33.82M-36.68M-28.13M-30.93M-31.64M
-0.39-0.51-0.44-0.49-0.73
CRDL annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
21.42M30.58M34.93M59.47M83.90M
23.62M31.86M36.70M62.03M87.88M
5.74M7.14M8.45M9.83M11.64M
125.52K158.53K174.34K72.87K117.58K
17.88M24.73M28.25M52.20M76.24M
CRDL annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-23.85M-25.06M-25.18M-27.22M-23.54M
-24.48K-21.29K-64.31K-74.71K-12.92K
15.54M18.84M-55.38K-53.93K93.44M
-24.48K-21.29K-64.31K-74.71K-12.92K
-8.34M-6.24M-25.30M-27.35M69.89M